cas 2940958-65-4|| where to buy 1-(4-bromo-2-methoxy-6-methyl-phenyl)-3-(2-trimethylsilylethoxymethyl)hexahydropyrimidine-2,4-dione

Nom du produit:1-(4-bromo-2-methoxy-6-methyl-phenyl)-3-(2-trimethylsilylethoxymethyl)hexahydropyrimidine-2,4-dione

IUPAC Name:1-(4-bromo-2-methoxy-6-methylphenyl)-3-{[2-(trimethylsilyl)ethoxy]methyl}-1,3-diazinane-2,4-dione

: CAS：2940958-65-4; Formule moléculaire：C18H27BrN2O4Si; Pureté：95%

Unité d'emballage	Stock disponible	Prix($)
CM1076998-100mg	in stock	ŞǑƿ
CM1076998-250mg	in stock	ȯƥƿ
CM1076998-500mg	in stock	ƥƿƛ
CM1076998-1g	in stock	ŪŪƿƃ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2940958-65-4 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2940958-65-4; Formule moléculaire:C18H27BrN2O4Si; Point de fusion:-; Code SMILES:COC1=CC(Br)=CC(C)=C1N1CCC(=O)N(COCC[Si](C)(C)C)C1=O; Densité:

: Numéro de catalogue:CM1076998; Poids moléculaire:443.41; Point d'ébullition:; N° Mdl:; Stockage:

: PROTAC-E3 Ligase Ligands; Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.; PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules; Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules; PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.